This entry-level pharmacovigilance course provides an introduction to the principles and concepts of pharmacovigilance, the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.
The course covers global regulatory requirements for pharmacovigilance, including reporting timelines, submission requirements, and reporting channels. It also explores different types of pharmacovigilance data sources, such as spontaneous reports, clinical trials, and observational studies, and how to manage this data effectively using common pharmacovigilance tools and databases.
Students will learn about the roles and responsibilities of different stakeholders in pharmacovigilance, including regulatory agencies, pharmaceutical companies, healthcare professionals, and patients. They will also explore risk management in pharmacovigilance, including signal detection, risk assessment, and risk minimization strategies.
Throughout the course, students will become familiar with pharmacovigilance terminology, abbreviations, and acronyms, and will also discuss ethical considerations and challenges associated with pharmacovigilance, such as confidentiality, informed consent, and data privacy.
Finally, the course will emphasize the importance of communication and teamwork in pharmacovigilance, and provide opportunities for students to develop these skills through group activities and case studies. Upon completion, students should be able to understand the fundamental concepts and practices of pharmacovigilance and contribute to ensuring patient safety.